CV Sciences (CVSI) Net Margin (2013 - 2026)

CV Sciences' (CVSI) quarterly Net Margin came in at 20.13% in Q1 2026, down 1710.0% year-on-year from 1.25% in Q1 2025, and down 275.6% quarter-over-quarter from 11.46% in Q4 2025.

CV Sciences (CVSI) Net Margin (2013 - 2026) Analysis & Trends

CV Sciences has disclosed Net Margin across 14 years of filings, most recently posting 20.13% for Q1 2026.

  • Net Margin for Q1 2026 came in at 20.13%, down 1710.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.78% (up 547.0% YoY), and the FY2025 annual result was 2.71%, up 1254.0% from the prior year.
  • Net Margin came in at 20.13% for Q1 2026 at CV Sciences, down from 11.46% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 137.56% in Q1 2023 to a low of 86.35% in Q2 2022.
  • The 5-year median for Net Margin is 15.69% (2024), against an average of 13.41%.
  • Across the five-year window, Net Margin surged 17163 bps in 2023 and sank 15325 bps in 2024, its largest moves.
  • CV Sciences' Net Margin stood at 59.78% in 2022, then surged by 62 bps to 22.86% in 2023, then grew by 18 bps to 18.69% in 2024, then jumped by 161 bps to 11.46% in 2025, then tumbled by 276 bps to 20.13% in 2026.
  • The last three Net Margin figures came in at 20.13% (Q1 2026), 11.46% (Q4 2025), and 11.73% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 9.19%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 26.57%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 35.18%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 2.94%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 24.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 4.16%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -168.42%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 31.38%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -15.15%
10 CV Sciences - - 1.56 Mn -20.13%

Historic Data

Download Data
DateValue
Mar 31, 2026 -20.13%
Dec 31, 2025 11.46%
Sep 30, 2025 -11.73%
Jun 30, 2025 -7.21%
Mar 31, 2025 -3.02%
Dec 31, 2024 -18.69%
Sep 30, 2024 -11.80%
Jun 30, 2024 -14.77%
Mar 31, 2024 -15.69%
Dec 31, 2023 -22.86%
Sep 30, 2023 -10.93%
Jun 30, 2023 -32.48%
Mar 31, 2023 137.56%
Dec 31, 2022 -59.78%
Sep 30, 2022 -27.49%
Jun 30, 2022 -86.35%
Mar 31, 2022 -34.07%
Dec 31, 2021 -178.25%
Sep 30, 2021 -0.78%
Jun 30, 2021 -68.84%